HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serotonin syndrome:case report and current concepts.

Abstract
Selective serotonin reuptake inhibitors (SSRI's) are increasingly being used as the first line therapeutic agent for the depression. It is therefore not unusual to see a case of overdose with these agents. More commonly an adverse drug reaction may be seen among the older patients who are particularly vulnerable to the serotonin syndrome due to multiple co-morbidity and polypharmacy. The clinical picture of serotonin syndrome (SS) is non-specific and there is no confirmatory test. SS may go unrecognized because it is often mistaken for a viral illness, anxiety, neurological disorder or worsening psychiatric condition.
AuthorsJ Fennell, M Hussain
JournalIrish medical journal (Ir Med J) Vol. 98 Issue 5 Pg. 143-4 (May 2005) ISSN: 0332-3102 [Print] Ireland
PMID16010782 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cyclohexanols
  • Serotonin Uptake Inhibitors
  • Venlafaxine Hydrochloride
Topics
  • Adolescent
  • Cyclohexanols (poisoning)
  • Drug Overdose
  • Female
  • Humans
  • Serotonin Syndrome (chemically induced, diagnosis, physiopathology)
  • Selective Serotonin Reuptake Inhibitors (poisoning)
  • Venlafaxine Hydrochloride

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: